Clinical Trial: An Open-label Study to Evaluate the Absorption, Metabolism, and Excretion of [14C]-Telotristat Etiprate in Males

Study Status: Completed
Recruit Status: Completed
Study Type: Interventional

---

Official Title: A Phase 1, Open-label, Non-randomised, Single-dose Study to Evaluate the Absorption, Metabolism, and Excretion of [14C]-Telotristat Etiprate (LX1606) in Healthy Male Subjects

Brief Summary: To evaluate the metabolism and routes and extent of elimination of telotristat etiprate and its primary metabolite LX1033.